Transgene Sa Stock Price on April 12, 2024
| TRGNF Stock | USD 1.59 0.00 0.00% |
If you're considering investing in Transgene Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Transgene stands at 1.59, as last reported on the 1st of December, with the highest price reaching 1.59 and the lowest price hitting 1.59 during the day. We have found three technical indicators for Transgene SA, which you can use to evaluate the volatility of the company.
Transgene Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.
Transgene |
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| TRGNF |
Based on monthly moving average Transgene is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Transgene by adding Transgene to a well-diversified portfolio.
Related Headline
Luxfer Holdings Headline on 12th of April 2024
Filed transaction by Luxfer Holdings PLC Officer General Counsel Secretary. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Transgene Valuation on April 12, 2024
It is possible to determine the worth of Transgene on a given historical date. On April 12, 2024 Transgene was worth 1.62 at the beginning of the trading date compared to the closed value of 1.62. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Transgene pink sheet. Still, in general, we apply an absolute valuation method to find Transgene's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Transgene where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Transgene's related companies.
| Open | High | Low | Close | Volume | |
| 1.62 | 1.62 | 1.62 | 1.62 | 1.00 | |
04/12/2024 | 1.62 | 1.62 | 1.62 | 1.62 | 1.00 |
| 1.62 | 1.62 | 1.62 | 1.62 | 1.00 |
| Backtest Transgene | | | Transgene History | | | Transgene Valuation | Previous | Next |
Transgene Trading Date Momentum on April 12, 2024
| On April 15 2024 Transgene SA was traded for 1.62 at the closing time. The highest daily price throughout the period was 1.62 and the lowest price was 1.62 . There was no trading activity during the period 1.0. Lack of trading volume on 04/15/2024 did not result in any price rise and fall. The trading price change to current closing price is 0.00% . |
Transgene SA Fundamentals Correlations and Trends
By evaluating Transgene's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Transgene's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Transgene financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Transgene Pink Sheet history
Transgene investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Transgene is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Transgene SA will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Transgene stock prices may prove useful in developing a viable investing in Transgene
Transgene SA, a biotechnology company, focuses on designing and developing therapeutic vaccines and oncolytic viruses for the treatment of cancer and infectious diseases. The company was incorporated in 1979 and is headquartered in Illkirch-Graffenstaden, France. Transgene operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 143 people.
Transgene Pink Sheet Technical Analysis
Transgene technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Price Boundaries
Transgene Period Price Range
Low | December 1, 2024
| High |
0.00 | 0.00 |
Transgene SA cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Transgene December 1, 2024 Market Strength
Market strength indicators help investors to evaluate how Transgene pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Transgene shares will generate the highest return on investment. By undertsting and applying Transgene pink sheet market strength indicators, traders can identify Transgene SA entry and exit signals to maximize returns
Complementary Tools for Transgene Pink Sheet analysis
When running Transgene's price analysis, check to measure Transgene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Transgene is operating at the current time. Most of Transgene's value examination focuses on studying past and present price action to predict the probability of Transgene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Transgene's price. Additionally, you may evaluate how the addition of Transgene to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |